Invention Grant
- Patent Title: Creatine oral supplementation using creatine hydrochloride salt
-
Application No.: US15968858Application Date: 2018-05-02
-
Publication No.: US10342771B2Publication Date: 2019-07-09
- Inventor: Donald W. Miller , Jonathan L. Vennerstrom , Mark C. Faulkner
- Applicant: Vireo Systems, Inc. , Board of Regents of the University of Nebraska
- Applicant Address: US TN Madison US NE Lincoln
- Assignee: Vireo Systems, Inc.,Board of Regents of the University of Nebraska
- Current Assignee: Vireo Systems, Inc.,Board of Regents of the University of Nebraska
- Current Assignee Address: US TN Madison US NE Lincoln
- Agency: Bradley Arant Boult Cummings LLP
- Main IPC: A23L2/52
- IPC: A23L2/52 ; A61K9/00 ; A23K20/10 ; A23K50/10 ; A23L33/10 ; A23P10/40 ; A23K20/105 ; A23K20/142 ; A23L33/175 ; A61K31/185 ; A61K31/195 ; A61K31/198 ; A61K31/661
Abstract:
The present invention is directed to an oral supplement including creatine hydrochloride, which has an aqueous solubility that is at least 15 times greater than creatine monohydrate, where the oral supplement drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine.
Public/Granted literature
- US20180250254A1 CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT Public/Granted day:2018-09-06
Information query
